During the past decade, Universitätsklinikum Essen; Klinik für Kinderheilkunde I conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Essen; Klinik für Kinderheilkunde I" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Essen; Klinik für Kinderheilkunde I" are "Atypical Hemolytic Uremic Syndrome" (1 trials), "Duchenne Muscular Dystrophy" (1 trials), "Pediatric Immuno-Tolerant Chronic Hepatitis B" (1 trials) and "Spinal Muscular Atrophy" (1 trials). Many other conditions were trialed in "Universitätsklinikum Essen; Klinik für Kinderheilkunde I" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Essen; Klinik für Kinderheilkunde I" are "Drug" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Crovalimab" (1 trials), "Entecavir" (1 trials), "Lamivudine" (1 trials), "Pegylated Interferon Alfa-2A" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Essen; Klinik für Kinderheilkunde I" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Universitätsklinikum Essen; Klinik für Kinderheilkunde I". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universitätsklinikum Essen; Klinik für Kinderheilkunde I, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Essen; Klinik für Kinderheilkunde I, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".